Crinetics News

Crinetics Pharmaceuticals Analyst Ratings

BenzingaMar 28 10:35 ET

Buy Rating Affirmed for Crinetics Pharmaceuticals Amid Impressive Paltusotine Trial Results

TipRanksMar 21 02:15 ET

Oppenheimer Raises Crinetics Pharmaceuticals Price Target to $55 From $54, Maintains Outperform Rating

MT NewswiresMar 20 08:45 ET

Analysts Offer Insights on Healthcare Companies: Nyxoah (NYXH), Tyra Bioscience (TYRA) and Crinetics Pharmaceuticals (CRNX)

TipRanksMar 20 08:00 ET

Crinetics Pharmaceuticals Analyst Ratings

BenzingaMar 19 12:23 ET

HC Wainwright & Co. Reiterates Buy on Crinetics Pharmaceuticals, Maintains $50 Price Target

BenzingaMar 19 12:24 ET

Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX) and Biogen (BIIB)

TipRanksMar 19 08:40 ET

Crinetics Pharmaceuticals Earns 'Buy' Rating on Clinical Success and Market Expansion Potential

TipRanksMar 15 01:25 ET

Analysts Offer Insights on Healthcare Companies: ProQR (PRQR) and Crinetics Pharmaceuticals (CRNX)

TipRanksMar 13 13:20 ET

Crinetics Pharmaceuticals Analyst Ratings

BenzingaMar 13 07:27 ET

Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Belite Bio, Inc. ADR (BLTE) and Prothena (PRTA)

TipRanksMar 13 06:20 ET

Buy Rating Affirmed for Crinetics Pharmaceuticals as Paltusotine Shows Promising Phase 2 Results and Market Potential

TipRanksMar 13 00:25 ET

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD) and Crinetics Pharmaceuticals (CRNX)

TipRanksMar 11 07:01 ET

Crinetics Pharmaceuticals Analyst Ratings

BenzingaMar 8 06:36 ET

Crinetics Pharmaceuticals Analyst Ratings

BenzingaMar 6 05:18 ET

Crinetics Pharmaceuticals Analyst Ratings

BenzingaMar 4 10:27 ET

Crinetics Pharmaceuticals (CRNX) Gets a Buy From Piper Sandler

TipRanksMar 4 07:57 ET

Strong Buy Rating for Crinetics Pharmaceuticals Amidst Financial Fortitude and Promising Clinical Trials

TipRanksFeb 29 14:05 ET

Crinetics Pharmaceuticals Analyst Ratings

BenzingaFeb 29 10:38 ET

Analysts Are Bullish on Top Healthcare Stocks: Day One Biopharmaceuticals (DAWN), Crinetics Pharmaceuticals (CRNX)

TipRanksFeb 29 08:10 ET